Position in ATRA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$348,360
+$188,156 QoQ
Shares Held
30,345
-10.4% QoQ
Ownership
0.302%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 36 holders
Holding Since
Jun 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ATRA Over Time
Shares Held
Position Value (USD)
Derivatives in ATRA
reported options exposure · as of Mar 31, 2022CallValue
$184,871
CallShares
796
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026JANE STREET GROUP, LLC holds $1,372,940,661 across 293 Biotechnology names. ATRA ranks #140 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
2,934,193 | $218,538,693 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
191,541 | $102,847,939 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
403,995 | $98,885,855 | |
| 4 | TGTX |
Tg Therapeutics, Inc.
|
1,752,646 | $96,290,370 | |
| 5 | EXEL |
Exelixis, Inc.
|
1,402,438 | $76,306,651 | |
| 6 | QURE |
uniQure N.V.
|
1,610,483 | $74,178,846 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
694,684 | $54,372,915 | |
| 8 | TVTX |
Travere Therapeutics, Inc.
|
938,699 | $53,327,489 |
All Filings in ATRA
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $348,360 | 30,345 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $160,204 | 33,870 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $253,078 | 13,990 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $316,119 | 22,060 | Shares | Defined | 2025-11-14 | |
| 2024-03-31 | $43,479 | 62,651 | Shares | Defined | 2024-05-16 | |
| 2023-12-31 | $67,805 | 132,177 | Shares | Defined | 2024-02-15 | |
| 2023-09-30 | $34,637 | 23,404 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $711,250 | 441,771 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $52,945 | 18,257 | Shares | Defined | 2023-05-16 | |
| 2022-12-31 | $485,462 | 148,007 | Shares | Defined | 2023-02-15 | |
| 2022-09-30 | $294,514 | 77,914 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $195,886 | 25,146 | Shares | Defined | 2022-08-16 | |
| 2022-03-31 | $184,871 | 19,900 | Call | Defined | 2022-05-17 | |
| 2021-12-31 | $207,590 | 13,172 | Shares | Defined | 2022-02-15 | |
| 2021-12-31 | $327,808 | 20,800 | Call | Defined | 2022-02-15 | |
| 2021-09-30 | $182,580 | 10,200 | Call | Defined | 2021-11-16 | |
| 2021-09-30 | $423,764 | 23,674 | Shares | Defined | 2021-11-16 | |
| 2021-06-30 | $229,828 | 14,780 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $314,411 | 21,895 | Shares | Defined | 2021-05-18 | |
| 2020-12-31 | $598,282 | 30,478 | Shares | Defined | 2021-02-17 | |
| 2020-12-31 | $284,635 | 14,500 | Call | Defined | 2021-02-17 | |
| 2020-12-31 | $280,709 | 14,300 | Put | Defined | 2021-02-17 | |
| 2020-09-30 | $1,401,351 | 108,129 | Shares | Defined | 2020-11-17 | |
| 2020-06-30 | $247,893 | 17,014 | Shares | Defined | 2020-08-17 | |
| No filing history on record for this holder in this stock. | ||||||